388 related articles for article (PubMed ID: 24788044)
1. Decreased expression of Sox7 correlates with the upregulation of the Wnt/β-catenin signaling pathway and the poor survival of gastric cancer patients.
Cui J; Xi H; Cai A; Bian S; Wei B; Chen L
Int J Mol Med; 2014 Jul; 34(1):197-204. PubMed ID: 24788044
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer.
Chan DW; Mak CS; Leung TH; Chan KK; Ngan HY
Oncotarget; 2012 Dec; 3(12):1546-56. PubMed ID: 23295859
[TBL] [Abstract][Full Text] [Related]
3. Wnt pathway is involved in advanced gastric carcinoma.
Zhang H; Xue Y
Hepatogastroenterology; 2008; 55(84):1126-30. PubMed ID: 18705344
[TBL] [Abstract][Full Text] [Related]
4. Reduced expression of SOX7 in ovarian cancer: a novel tumor suppressor through the Wnt/β-catenin signaling pathway.
Liu H; Yan ZQ; Li B; Yin SY; Sun Q; Kou JJ; Ye D; Ferns K; Liu HY; Liu SL
J Ovarian Res; 2014 Sep; 7():87. PubMed ID: 25297608
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of SOX7 is correlated with poor prognosis in lung adenocarcinoma patients.
Li B; Ge Z; Song S; Zhang S; Yan H; Huang B; Zhang Y
Pathol Oncol Res; 2012 Oct; 18(4):1039-45. PubMed ID: 22777918
[TBL] [Abstract][Full Text] [Related]
6. SOX7 modulates the progression of hepatoblastoma through the regulation of Wnt/β-catenin signaling pathway.
Ge J; Zheng Q; Qu H; Zhao Z; Xu Y; Wang H; Gao H; Zhan J
J Cancer Res Ther; 2022 Apr; 18(2):370-377. PubMed ID: 35645102
[TBL] [Abstract][Full Text] [Related]
7. Nuclear translocations of beta-catenin and TCF4 in gastric cancers correlate with lymph node metastasis but probably not with CD44 expression.
Chen XY; Wang ZC; Li H; Cheng XX; Sun Y; Wang XW; Wu ML; Liu J
Hum Pathol; 2005 Dec; 36(12):1294-301. PubMed ID: 16311123
[TBL] [Abstract][Full Text] [Related]
8. KIAA1199 promotes migration and invasion by Wnt/β-catenin pathway and MMPs mediated EMT progression and serves as a poor prognosis marker in gastric cancer.
Jia S; Qu T; Wang X; Feng M; Yang Y; Feng X; Ma R; Li W; Hu Y; Feng Y; Ji K; Li Z; Jiang W; Ji J
PLoS One; 2017; 12(4):e0175058. PubMed ID: 28422983
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of circHIPK3 promotes the progression of gastric cancer via Wnt/β-catenin pathway and indicates a poor prognosis.
Liu WG; Xu Q
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7905-7912. PubMed ID: 31599413
[TBL] [Abstract][Full Text] [Related]
10. Slit2 expression and its correlation with subcellular localization of β-catenin in gastric cancer.
Shi R; Liu W; Liu B; Xu Z; Chen L; Zhang Z
Oncol Rep; 2013 Oct; 30(4):1883-9. PubMed ID: 23933755
[TBL] [Abstract][Full Text] [Related]
11. Sox17, the canonical Wnt antagonist, is epigenetically inactivated by promoter methylation in human breast cancer.
Fu DY; Wang ZM; Li-Chen ; Wang BL; Shen ZZ; Huang W; Shao ZM
Breast Cancer Res Treat; 2010 Feb; 119(3):601-12. PubMed ID: 19301122
[TBL] [Abstract][Full Text] [Related]
12. SOX7 co-regulates Wnt/β-catenin signaling with Axin-2: both expressed at low levels in breast cancer.
Liu H; Mastriani E; Yan ZQ; Yin SY; Zeng Z; Wang H; Li QH; Liu HY; Wang X; Bao HX; Zhou YJ; Kou JJ; Li D; Li T; Liu J; Liu Y; Yin L; Qiu L; Gong L; Liu SL
Sci Rep; 2016 May; 6():26136. PubMed ID: 27188720
[TBL] [Abstract][Full Text] [Related]
13. Hypermethylation of adenomatous polyposis coli gene promoter is associated with novel Wnt signaling pathway in gastric adenomas.
Wang ZK; Liu J; Liu C; Wang FY; Chen CY; Zhang XH
J Gastroenterol Hepatol; 2012 Oct; 27(10):1629-34. PubMed ID: 22741528
[TBL] [Abstract][Full Text] [Related]
14. CHD8 is an independent prognostic indicator that regulates Wnt/β-catenin signaling and the cell cycle in gastric cancer.
Sawada G; Ueo H; Matsumura T; Uchi R; Ishibashi M; Mima K; Kurashige J; Takahashi Y; Akiyoshi S; Sudo T; Sugimachi K; Doki Y; Mori M; Mimori K
Oncol Rep; 2013 Sep; 30(3):1137-42. PubMed ID: 23835524
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of FOXS1 in gastric cancer cell lines inhibits proliferation, metastasis, and epithelial-mesenchymal transition of tumor through downregulating wnt/β-catenin pathway.
Lu Q; Ma X; Li Y; Song W; Zhang L; Shu Y; Wan B
J Cell Biochem; 2019 Mar; 120(3):2897-2907. PubMed ID: 30500980
[TBL] [Abstract][Full Text] [Related]
16. LKB1 inhibits the proliferation of gastric cancer cells by suppressing the nuclear translocation of Yap and β-catenin.
Ma LG; Bian SB; Cui JX; Xi HQ; Zhang KC; Qin HZ; Zhu XM; Chen L
Int J Mol Med; 2016 Apr; 37(4):1039-48. PubMed ID: 26936013
[TBL] [Abstract][Full Text] [Related]
17. Alteration in the Wnt/β-catenin signaling pathway in gastric neoplasias of fundic gland (chief cell predominant) type.
Hidaka Y; Mitomi H; Saito T; Takahashi M; Lee SY; Matsumoto K; Yao T; Watanabe S
Hum Pathol; 2013 Nov; 44(11):2438-48. PubMed ID: 24011952
[TBL] [Abstract][Full Text] [Related]
18. The significance of NTR1 expression and its correlation with β-catenin and EGFR in gastric cancer.
Zhou Z; Xie J; Cai Y; Yang S; Chen Y; Wu H
Diagn Pathol; 2015 Jul; 10():128. PubMed ID: 26215716
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of long noncoding RNA LINC00460 expression suppresses tumor growth in vitro and in vivo in gastric cancer.
Zhang S; Xu J; Wang H; Guo H
Cancer Biomark; 2019; 24(4):429-437. PubMed ID: 30909185
[TBL] [Abstract][Full Text] [Related]
20. AKR1B10, a good prognostic indicator in gastric cancer.
Yao HB; Xu Y; Chen LG; Guan TP; Ma YY; He XJ; Xia YJ; Tao HQ; Shao QS
Eur J Surg Oncol; 2014 Mar; 40(3):318-24. PubMed ID: 24406159
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
